ISG20:癌症研究中的多方面的"分子明星" (综述)
Xinhui Zhu1, Shihao Jiang1, Lipeng Zhang1
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Oncology reports
|September 12, 2025
概括
干扰素刺激基因 (ISG) 20是免疫和新陈代谢中的关键蛋白质,在癌症中表现出复杂的作用. 这篇评论探讨了ISG20的情况.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 干扰素刺激基因 (ISG) 20通过其外核酶活性,是抗病毒防御,免疫调节和细胞代谢的组成部分.
- 在清细胞细胞癌,质瘤,乳腺癌和肝细胞癌中观察到ISG20失调,与瘤进展和免疫逃避相关.
研究的目的:
- 审查ISG20的发现,结构和功能.
- 阐明ISG20在瘤发育中的多方面的作用及其在癌症生物学中的双重调控功能.
- 讨论ISG20作为精密瘤学的生物标志物,免疫辅助剂和治疗点的潜力.
主要方法:
- 对ISG20的发现,结构和功能进行文献综述.
- 对ISG20在各种恶性瘤中的参与进行分析.
- 对ISG20的信号通路进行检查 (例如,MMP9/CCND1,IFN-β).
主要成果:
- ISG20表现出双重作用:通过MMP9/CCND1促进瘤进展,并通过IFN-β增强抗瘤免疫力.
- ISG20的失调与多种癌症中的瘤扩散,转移,血管生成和免疫逃避有关.
- 在瘤生物学中ISG20的复杂参与被其多样化的调节功能所突出.
结论:
- ISG20是癌症发展的关键因素,对瘤生物学有重大影响.
- 在精密瘤学中,ISG20具有作为一种新的生物标志物和治疗点的潜力.
- 对ISG20的进一步研究可能为癌症治疗和免疫治疗提供转化见解.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K